Hi-Lab
Latest round
- Angel
Last raised
- Dec 2025
Total raised
- $8.5M
Investors
- 5
About Hi-Lab
, dba Hi-Lab, focuses on advancing the discovery and development of First-in-Class and Best-in-Class antibody drug candidates. The company engages in domestic and international pipeline collaborations to support global biopharmaceutical innovation. The company conducts research and development of multi-specific and bispecific antibody therapeutics with applications in cancer, autoimmune, and metabolic disease treatment. Its services include biologic design, preclinical evaluation, and partnership-driven clinical development support. The company generates revenue from research collaborations, licensing of its therapeutic technologies, and development partnerships with biopharmaceutical organizations.
Who invested in Hi-Lab
5 investors across 1 round
See all investors in Hi-Lab
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Dec 25, 2025
Amount
$8.5M
Investors
Questions about Hi-Lab
Who invested in Hi-Lab?
Hi-Lab has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hi-Lab raised?
Hi-Lab has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hi-Lab last raise money?
Hi-Lab's most recent round on record is a Angel, in Dec 2025.
What does Hi-Lab do?
, dba Hi-Lab, focuses on advancing the discovery and development of First-in-Class and Best-in-Class antibody drug candidates.
Where is Hi-Lab headquartered?
Hi-Lab is headquartered in Beijing, China.
Which VCs invest in companies like Hi-Lab?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Hi-Lab's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Hi-Lab? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.